Abu-Shahba, et al.10 (2023) reported that patients with high expression of POU2F1 or low expression of PPARA exhibited low survival probability and vice versa (p≤0.05) in HCC. The gene discussed is POU2F1; the disease is hepatocellular carcinoma.